companydata.dkcompanydata.dk

AMBU A/S: Financial statements 2022

CVR: 63644919

Source: annual report 2022, Danish Business Authority

01/10/202130/09/2022

AMBU A/S (CVR 63644919) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 4,444,000,000 and a net result of DKK 93,000,000 compared with DKK 247,000,000 the year before. That is an increase of 10.7% compared with the year before. The profit margin was 2.1%. Equity in the 2022 report amounted to DKK 4,261,000,000. The solvency ratio was 59.1%.

Revenue
DKK 4,444,000,000
Gross Profit
DKK 2,554,000,000
Profit/Loss
DKK 93,000,000
Equity
DKK 4,261,000,000
Total Assets
DKK 7,215,000,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20224.4 mia.2.6 mia.93 mio.4.3 mia.-
20214 mia.2.5 mia.247 mio.4 mia.-
20203.6 mia.2.2 mia.241 mio.2.4 mia.-
20192.8 mia.1.6 mia.317 mio.2.2 mia.-
20182.6 mia.-337 mio.1.9 mia.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on AMBU A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

AMBU A/S publishes interim reportDec 23, 2022

AMBU A/S has published its interim report for the period October 1, 2021 – June 30, 2022.

Simon Hesse Vangsted Hoffmann joins the board of AMBU A/SDec 14, 2022

As of December 14, 2022, Simon Hesse Vangsted Hoffmann has joined the board of directors of AMBU A/S.

Shacey Marie Petrovic joins the board of AMBU A/SDec 14, 2022

As of December 14, 2022, Shacey Marie Petrovic has joined the board of directors of AMBU A/S.

Thomas Frederik Schmidt joins AMBU A/S as directorJun 1, 2022

As of June 1, 2022, Thomas Frederik Schmidt is registered as director of AMBU A/S.

Michael Højgaard Abrahamsen steps down as director of AMBU A/SMay 31, 2022

As of May 31, 2022, Michael Højgaard Abrahamsen has stepped down as director of AMBU A/S.

Britt Meelby Jensen joins AMBU A/S as adm. dir.May 20, 2022

As of May 20, 2022, Britt Meelby Jensen is registered as adm. dir. of AMBU A/S.

Britt Meelby Jensen leaves the board of AMBU A/SMay 19, 2022

As of May 19, 2022, Britt Meelby Jensen has left the board of directors of AMBU A/S.

Juan Jose Gonzalez Casanova steps down as adm. dir. of AMBU A/SMay 19, 2022

As of May 19, 2022, Juan Jose Gonzalez Casanova has stepped down as adm. dir. of AMBU A/S.

AMBU A/S publishes interim reportMay 12, 2022

AMBU A/S has published its interim report for the period October 1, 2021 – March 31, 2022.

AMBU A/S publishes interim reportApr 22, 2022

AMBU A/S has published its interim report for the period October 1, 2021 – December 31, 2021.

About AMBU A/S

AMBU A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1956. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named AMBU INTERNATIONAL A/S and TESTA-LABORATORIUM A/S. The management consists of Britt Meelby Jensen and Henrik Skak Bender. The board consists of Jørgen Falkebo Jensen (chair), Shacey Marie Petrovic, David Lippincott Hale and Eva Marie Susanne Larsson. The company's owners include Anne-Mette Ragle, Pia Hesse and Kim Ragle. The company has 223 employees (2018). In 2025, the company reported revenue of DKK 6,037,000,000 and a net result of DKK 609,000,000 compared with DKK 235,000,000 the year before. Equity in the 2025 report amounted to DKK 6,035,000,000.

Source: annual report 2025, Danish Business Authority